The Src-protein tyrosine kinase Lck is required for IL-1-mediated costimulatory signaling in Th2 cells

J Immunol. 2001 Dec 15;167(12):6827-33. doi: 10.4049/jimmunol.167.12.6827.

Abstract

Src-protein tyrosine kinases are intimately involved in TCR-initiated signaling in T lymphocytes. One member of this family, Lck, is also involved in CD28-mediated costimulation in Th1 cells. In Th2 lymphocytes, the costimulatory signal can also be provided by the interaction of IL-1 with type I IL-1R (IL-1RI), culminating in the activation of NF-kappaB transcription factors. Proximal steps in the IL-1R pathway, however, remain poorly understood, and there is conflicting evidence as to the importance of tyrosine phosphorylation in IL-1R signaling. We have addressed this issue by examining the ability of IL-1 to costimulate the activation of Lck-deficient Th2 cells. Our data demonstrate that, in the absence of Lck, the IL-1 costimulatory pathway is blocked despite the expression of normal levels of IL-1RI. Moreover, the block is associated with a defective degradation of IkappaB-alpha and an incomplete activation of NF-kappaB heterodimeric complexes. Protein expression of NF-kappaB monomers, including p50, p65, and c-Rel, is equivalent in both wild-type and Lck-deficient Th2 cell clones. Finally, we demonstrate that, in normal Th2 cells, stimulation with IL-1 leads to a rapid induction in tyrosine phosphorylation of several substrates including Lck itself. These findings strongly suggest that Lck is required for signaling in the IL-1 costimulatory pathway in Th2 lymphocytes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Clone Cells
  • DNA-Binding Proteins / metabolism
  • Dose-Response Relationship, Drug
  • I-kappa B Proteins*
  • Interleukin-1 / pharmacology*
  • Kinetics
  • Lymphocyte Activation*
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck) / genetics
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck) / physiology*
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / metabolism
  • NF-kappa B p50 Subunit
  • Phosphorylation
  • Proto-Oncogene Proteins c-rel / metabolism
  • RNA, Antisense / pharmacology
  • Receptors, Interleukin-1 / metabolism
  • Receptors, Interleukin-1 Type I
  • Signal Transduction*
  • Th2 Cells / immunology*
  • Transcription Factor RelA

Substances

  • DNA-Binding Proteins
  • I-kappa B Proteins
  • Interleukin-1
  • NF-kappa B
  • NF-kappa B p50 Subunit
  • Proto-Oncogene Proteins c-rel
  • RNA, Antisense
  • Receptors, Interleukin-1
  • Receptors, Interleukin-1 Type I
  • Transcription Factor RelA
  • NF-KappaB Inhibitor alpha
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck)